Globus Medical, Inc. Class A Common Stock (GMED)
EBITDA
$945.76M
TTM · Period ending: · USD
GMED EBITDA
Latest reported$945.76Mperiod ending
Latest reported$945.76Mperiod ending
GMED EBITDA ($97.30M → $945.76M)
Annual EBITDA
High-resolution chart · PNG
GMED ebitda history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA (USD) |
|---|---|
| 886,742,000 | |
| 473,725,000 | |
| 346,583,000 | |
| 304,503,000 | |
| 264,725,000 | |
| 178,346,000 | |
| 229,488,000 | |
| 218,514,000 | |
| 205,387,000 | |
| 192,993,000 | |
| 195,585,000 | |
| 159,591,000 | |
| 120,931,000 | |
| 132,681,000 | |
| 115,781,000 | |
| 105,668,000 | |
| 97,296,000 |